<DOC>
	<DOC>NCT01180907</DOC>
	<brief_summary>The purpose of the study is to determine whether positron emission tomography using the new imaging agent 18F-FAC can be used for imaging cancer and/or inflammation.</brief_summary>
	<brief_title>The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<criteria>&gt; 18 years of age women of childbearing potential will undergo a pregnancy test free of charge patients with cancer or autoimmune diseases or healthy subjects</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>18F-FAC</keyword>
	<keyword>imaging</keyword>
	<keyword>cancer</keyword>
	<keyword>inflammation</keyword>
	<keyword>PET</keyword>
</DOC>